Page last updated: 2024-08-21

d-alpha tocopherol and naloxone

d-alpha tocopherol has been researched along with naloxone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's3 (30.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Boyd, AJ; Mamelak, M; Saibil, FG; Sherman, IA1
Bakuleva, LP; Iarygin, KN; Kryzhanovskiĭ, GN; Luzina, NL; Vinogradov, VA1
Kuo, JS; Tsai, PJ; Wu, JP; Yang, CS1
Ainsah, O; Khalid, BA; Nabishah, BM; Osman, CB1
Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T1
Accinni, R; Cighetti, G; Pinelli, A; Trivulzio, S1
Birdane, YO; Bulut, S; Büyükokuroğlu, ME; Cemek, M; Hazman, O; Konuk, M1

Reviews

2 review(s) available for d-alpha tocopherol and naloxone

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for d-alpha tocopherol and naloxone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster.
    Gastroenterology, 1990, Volume: 99, Issue:3

    Topics: Allopurinol; Animals; Cricetinae; Hydroxybutyrates; Intestines; Ischemia; Male; Mesocricetus; Naloxone; Reperfusion Injury; Sodium Oxybate; Vitamin E

1990
[Endogenous opioid system in the realization of the analgesic effect of alpha-tocopherol in reference to algomenorrhea].
    Biulleten' eksperimental'noi biologii i meditsiny, 1988, Volume: 105, Issue:2

    Topics: Adult; alpha-Tocopherol; Analgesia; beta-Endorphin; Chronic Disease; Dysmenorrhea; Endorphins; Female; Humans; Menstruation; Naloxone; Tocopherols; Vitamin E

1988
Ferrous ion diminished the antiarrhythmic effect of naloxone in myocardial ischemia of isolated rat hearts.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:7

    Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Ferrous Compounds; Heart; Male; Myocardial Ischemia; Myocardium; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Vitamin E

1998
Naloxone and vitamin E block stress-induced reduction of locomotor activity and elevation of plasma corticosterone.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1999, Volume: 107, Issue:7

    Topics: Animals; Corticosterone; Male; Motor Activity; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Stress, Physiological; Vitamin E

1999
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
    Behavioural pharmacology, 2007, Volume: 18, Issue:8

    Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides

2007
Morphine or its withdrawal affects plasma malondialdehyde, vitamin E levels and absence or presence of abstinence signs in rats.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:4

    Topics: Animals; Isoproterenol; Male; Malondialdehyde; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Vitamin E

2009
The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxone-precipitated withdrawal in heroin-addicted rats.
    Biological trace element research, 2011, Volume: 142, Issue:1

    Topics: Animals; Antioxidants; Ceruloplasmin; Glutathione; Heroin; Heroin Dependence; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Naloxone; Nitrates; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Selenium; Substance Withdrawal Syndrome; Vitamin E

2011